Biomarkers are biological molecules or genes that are generally used as diagnostics tool to measure and evaluate pharmacological, pathogenic and biological processes. Biomarkers are generally found in biological systems, tissues, blood and other bodily fluids. In pharmacological applications, it is used to observe body’s response to a particular treatment to disease or condition. Biomarkers are also used to detect, predict and monitor progression of diseases like cancer metastasis, autoimmune diseases and others.
Global biomarker market can be classified on the basis of product, type and application. By type, biomarkers are segmented as safety, efficacy and validation biomarkers wherein demand for surrogate efficacy biomarkers is expected to be the highest due to its implementation across various research activities. Biomarkers are used across various applications such as diagnostics development, personalized medicine, drug discovery & development. Out of these application areas, while diagnostics development is expected to account for majority of the market share, personalized medicine is expected to grow at the highest rate.
North America is expected to witness the highest growth rate due to increasing acceptance of advanced technologies and wider application portfolio.
Currently industry is focusing on research & development of various biomarker identification technologies involving genomics, proteomics, metabolomics, imaging and gene expression over wide range of tools including nanobiotechnology, mass or liquid spectrometry/chromatography, nuclear magnetic resonance (NMR), fluorescent indicators and lab-on-chips. Diagnostic biomarkers for cancer is another field that holds promising growth prospect in the future.
Increasing prevalence of cancer, immunological, neurological and other disorders and steady growth of technological advancements in global biomarker market are expected to drive growth. Other factors like low cost of clinical trials across developing countries and growing healthcare and R&D expenditure by governments are also contributing to the progress of biomarkers market. However, poor regulatory & reimbursement framework, high capital investments, high costs associated with sample collection, tests & storage and low cost-benefit ratio will restrain the growth of the market.
ASDReport.com has a good collection of reports on biomarkers. The reports provide insights on various applications and tests related to biomarkers like, cancer biomarkers, ALT/SGPT, cancer biomarkers, among others.